The free-energy surface (FES) of protein-ligand binding contains information useful for drug design. Here we show how to exploit a free-energy minimum of a protein-ligand complex identified by metadynamics simulations to design a new EphA2 antagonist with improved inhibitory potency.
Keywords: computational chemistry; drug design; metadynamics; steroids; surface plasmon resonance.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.